Series B funding round for Immunitas Therapeutics raising $58M in August 2021
Series B funding round for Immunitas Therapeutics raising $58M in August 2021
| Investor | Firm Type | Partner |
|---|
Agent CapitalLEAD | Venture Capital | — |
| Private | — | |
| Foundation | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private Equity | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Corporate Venture Capital | — | |
| Venture Capital | — | |
| Angel | Netalie Nadivi |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$97M
Top Valuation
-
Immunitas Therapeutics raised $58M in a Series B round.
The round was announced on 08/01/21.
The round was led by Agent Capital.